Anticancer mechanism of breviscapine in non-small cell lung cancer A549 cells acts via ROS-mediated upregulation of IGFBP4

BACKGROUND: The overall 5-year survival rate of non-small cell lung cancer (NSCLC) is less than 15% because of multiple drug resistance to chemotherapy and the limitations of early diagnosis. Thus, safe and effective drugs to treat NSCLC are required. The present study aimed to investigate the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Weitian, Wang, Liang, Xu, Liwei, Zeng, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107560/
https://www.ncbi.nlm.nih.gov/pubmed/34012594
http://dx.doi.org/10.21037/jtd-21-551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107560/
https://www.ncbi.nlm.nih.gov/pubmed/34012594
http://dx.doi.org/10.21037/jtd-21-551

Ejemplares similares